What is the difference between large fiber polyneuropathy, mononeuropathy, and small fiber polyneuropathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The main difference between large fiber neuropathy, mononeuropathy, and small fiber polyneuropathy lies in the types of nerves affected and the pattern of involvement, with large fiber neuropathy affecting myelinated A-alpha and A-beta nerve fibers, mononeuropathy involving damage to a single peripheral nerve, and small fiber polyneuropathy affecting unmyelinated C-fibers and thinly myelinated A-delta fibers, as noted in the most recent guidelines 1.

Key Differences

  • Large fiber neuropathy affects the myelinated A-alpha and A-beta nerve fibers responsible for vibration sense, proprioception, and motor function, typically causing symptoms like numbness, tingling, weakness, and loss of balance.
  • Mononeuropathy involves damage to a single peripheral nerve, resulting in symptoms confined to that nerve's distribution area, such as carpal tunnel syndrome affecting the median nerve.
  • Small fiber polyneuropathy affects the unmyelinated C-fibers and thinly myelinated A-delta fibers that transmit pain and temperature sensations, causing burning pain, abnormal temperature sensations, and autonomic dysfunction like sweating abnormalities.

Diagnostic Approaches

  • Large fiber neuropathy is often detectable on nerve conduction studies.
  • Mononeuropathy shows abnormalities in a single nerve distribution.
  • Small fiber neuropathy requires specialized tests like skin biopsy for small nerve fiber density or quantitative sensory testing since routine nerve conduction studies are often normal, as highlighted in recent research 1.

Clinical Implications

  • Early recognition and appropriate management of neuropathy in people with diabetes is crucial, as emphasized in the latest standards of care 1.
  • Glycemic control can effectively prevent diabetic peripheral neuropathy and cardiac autonomic neuropathy in type 1 diabetes and may modestly slow their progression in type 2 diabetes, but it does not reverse neuronal loss, as noted in previous studies 1.

From the Research

Differences between Large Fiber, Mono, Neuropathy, or Small Fiber Polyneuropathy

  • Large fiber neuropathy affects the larger nerve fibers, which are responsible for motor function, vibration, and proprioathy [(2,3)].
  • Mono neuropathy refers to the damage or dysfunction of a single peripheral nerve 4.
  • Neuropathy is a general term for nerve damage, which can affect any type of nerve fiber [(5,6)].
  • Small fiber polyneuropathy, also known as small fiber neuropathy (SFN), affects the small nerve fibers, including A-delta and C fibers, which are responsible for pain, temperature, and autonomic function [(2,3,4,5,6)].

Characteristics of Small Fiber Neuropathy

  • SFN is characterized by symptoms such as neuropathic pain, sensory disturbances, and autonomic dysfunction [(2,3,4,6)].
  • The diagnosis of SFN is often challenging and requires a combination of clinical evaluation, laboratory tests, and skin biopsy [(2,3,4,5,6)].
  • SFN can be caused by various factors, including metabolic diseases, immune-mediated disorders, genetic abnormalities, and vitamin deficiencies [(2,3,4,5,6)].

Diagnostic Criteria for Small Fiber Neuropathy

  • The diagnosis of SFN is based on a combination of clinical features, such as pain, sensory disturbances, and autonomic dysfunction, and abnormal diagnostic tests, including skin biopsy and quantitative sensory testing [(2,3,4,5,6)].
  • The diagnostic criteria for SFN include reduced intraepidermal nerve fiber density on skin biopsy and abnormal quantitative sensory testing results [(3,5,6)].

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Small fiber neuropathy.

Acta neurologica Scandinavica, 2022

Research

Small fiber neuropathy: a disabling and underrecognized syndrome.

Current opinion in pulmonary medicine, 2017

Research

Small-fiber neuropathy definition, diagnosis, and treatment.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.